M.D.C. Holdings, Inc. (MDC) to Issue Quarterly Dividend of $0.30 on November 27th

Share on StockTwits

M.D.C. Holdings, Inc. (NYSE:MDC) declared a quarterly dividend on Monday, October 28th, Zacks reports. Investors of record on Wednesday, November 13th will be paid a dividend of 0.30 per share by the construction company on Wednesday, November 27th. This represents a $1.20 annualized dividend and a yield of 3.20%. The ex-dividend date is Tuesday, November 12th.

Shares of M.D.C. stock opened at $37.55 on Friday. The company has a market capitalization of $2.35 billion, a P/E ratio of 10.23, a P/E/G ratio of 1.04 and a beta of 1.04. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.83 and a current ratio of 9.08. The company has a fifty day moving average of $42.86 and a 200 day moving average of $36.86. M.D.C. has a fifty-two week low of $25.77 and a fifty-two week high of $46.84.

M.D.C. (NYSE:MDC) last issued its earnings results on Wednesday, October 30th. The construction company reported $0.79 earnings per share for the quarter, missing the consensus estimate of $0.87 by ($0.08). The firm had revenue of $750.27 million during the quarter, compared to the consensus estimate of $767.23 million. M.D.C. had a return on equity of 12.73% and a net margin of 6.58%. The company’s quarterly revenue was down 2.1% on a year-over-year basis. During the same period in the prior year, the company posted $0.86 EPS. Analysts forecast that M.D.C. will post 3.54 EPS for the current year.

In other news, CFO Jean-Frederic Viret sold 3,159 shares of the company’s stock in a transaction dated Wednesday, September 18th. The shares were sold at an average price of $20.44, for a total transaction of $64,569.96. Also, Director David E. Blackford sold 4,000 shares of the company’s stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $42.40, for a total transaction of $169,600.00. Following the sale, the director now owns 14,266 shares in the company, valued at $604,878.40. The disclosure for this sale can be found here. In the last quarter, insiders sold 98,832 shares of company stock worth $4,248,023. Corporate insiders own 26.30% of the company’s stock.

MDC has been the topic of several research analyst reports. Cfra upgraded shares of M.D.C. from a “hold” rating to a “buy” rating in a research note on Thursday, October 31st. Wedbush boosted their price target on shares of M.D.C. from $35.00 to $41.00 and gave the stock a “neutral” rating in a research note on Friday, September 13th. Raymond James upgraded shares of M.D.C. from an “outperform” rating to a “strong-buy” rating and boosted their price target for the stock from $42.00 to $49.00 in a research note on Friday, September 13th. ValuEngine cut shares of M.D.C. from a “hold” rating to a “sell” rating in a research note on Thursday, October 31st. Finally, Zelman & Associates cut shares of M.D.C. from a “buy” rating to a “hold” rating in a research note on Thursday, October 31st. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, one has given a buy rating and two have issued a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $44.00.

M.D.C. Company Profile

M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.

Further Reading: How Investors Use a Balance Sheet

Dividend History for M.D.C. (NYSE:MDC)

Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Canaccord Genuity Raises TransDigm Group  Price Target to $620.00
Canaccord Genuity Raises TransDigm Group Price Target to $620.00
Gulfport Energy’s  Buy Rating Reaffirmed at Deutsche Bank
Gulfport Energy’s Buy Rating Reaffirmed at Deutsche Bank
Rubius Therapeutics  Price Target Cut to $18.00
Rubius Therapeutics Price Target Cut to $18.00
State of Tennessee Treasury Department Increases Stock Position in Tactile Systems Technology Inc
State of Tennessee Treasury Department Increases Stock Position in Tactile Systems Technology Inc
State of Tennessee Treasury Department Cuts Position in Selective Insurance Group
State of Tennessee Treasury Department Cuts Position in Selective Insurance Group
State of Tennessee Treasury Department Raises Stock Position in Virtusa Co.
State of Tennessee Treasury Department Raises Stock Position in Virtusa Co.


© 2006-2019 Ticker Report